Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2013
10/15/2013US8557848 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/15/2013US8557845 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10/15/2013US8557841 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/15/2013US8557836 Spiro-piperidine inhibitors
10/15/2013US8557826 Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557822 Carboxamide, sulfonamide and amine compounds and methods for using the same
10/15/2013US8557821 Microbiocidal heterocycles
10/15/2013US8557813 2-benzylpyridazinone derivatives as met kinase inhibitors
10/15/2013US8557812 Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof
10/15/2013CA2623160C Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
10/15/2013CA2592170C Glycine derivative and use thereof
10/10/2013WO2013152206A1 Novel triazole compounds that modulate hsp90 activity
10/10/2013WO2013152150A1 Heterocyclic compounds and their uses
10/10/2013WO2013151982A1 Methods and compounds useful in treating pruritus, and methods for identifying such compounds
10/10/2013WO2013151923A1 Pyrimidinone carboxamides as inhibitors of endothelial lipase
10/10/2013WO2013151877A1 Pyrimidinedione carboxamide inhibitors of endothelial lipase
10/10/2013WO2013149997A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149977A1 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators
10/10/2013WO2013149926A1 Process for the manufacturing of ccr3 inhibitors
10/10/2013WO2013149903A1 N- substituted hetero - bicyclic furanone derivatives for combating animal
10/10/2013WO2013149800A1 Carboxamide compounds and their use as calpain inhibitors v
10/10/2013WO2013149704A1 Cyclic amides as metap-2 inhibitors
10/10/2013WO2013120852A4 Intermediates for a novel process of preparing imatinib and related tyrosine kinase inhibitors
10/10/2013WO2013111163A3 Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
10/10/2013WO2013105118A8 A process for synthesis of syn azido epoxide and its use as intermediate for the synthesis of amprenavir & saquinavir
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013WO2012030944A3 Quinoline and isoquinoline derivatives for use as jak modulators
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267712 Aromatic ketone synthesis with amide reagents and related reactions
10/10/2013US20130267704 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
10/10/2013US20130267703 Compounds useful for treating aids
10/10/2013US20130267702 Ampk-activating heterocyclic compounds and methods for using the same
10/10/2013US20130267701 Ampk-activating heterocyclic compounds and methods for using the same
10/10/2013US20130267539 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
10/10/2013US20130267529 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists
10/10/2013US20130267525 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
10/10/2013US20130267524 Heterocyclic compounds and their uses
10/10/2013US20130267521 Heterocyclic compounds and uses thereof
10/10/2013US20130267519 1,2-pyridazines, 1,6-pyridazines and pyrimidines
10/10/2013US20130267516 Substituted cyclopentyl-azines as casr-active compounds
10/10/2013US20130267493 Indole and indazole compounds that activate ampk
10/10/2013US20130267492 Aryl sulfonamides
10/10/2013US20130267491 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them
10/10/2013US20130266590 Dimeric iap inhibitors
10/09/2013EP2647637A2 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
10/09/2013EP2647632A1 Preparation method of a-imatinib mesylate
10/09/2013EP2647628A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013EP2646430A2 Chemokine cxcr4 receptor modulators and used related thereto
10/09/2013EP2646429A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
10/09/2013EP2646428A1 Heterocyclic derivates preparation processes and medical uses thereof
10/09/2013EP2646427A1 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases
10/09/2013EP2646020A1 Indoles
10/09/2013CN103347874A Dimeric iap inhibitors
10/09/2013CN103347873A Pyrazole derivative and pest control agent
10/09/2013CN103347872A Bicyclic compound
10/09/2013CN103347864A Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/09/2013CN103347860A Nampt抑制剂 Nampt inhibitor
10/09/2013CN103347856A Multifunctional nitroxide derivatives and uses thereof
10/09/2013CN103342702A D-A-A type C<^>N ligand compound as well as C<^>N ring platinum complex and application thereof
10/09/2013CN103342698A Dual-fluorophore ratio fluorescence molecular probe for non-fluorescence resonance energy transfer and preparation method thereof
10/09/2013CN103342696A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases
10/09/2013CN103342695A 1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones
10/09/2013CN103342680A Benzazepine derivatives useful as vasopressin antagonists
10/09/2013CN103342628A Method for simultaneously extracting and separating solanesol and nicotine from tobacco
10/09/2013CN102584698B 2-substutied-3-quinolinic acid ethyl ester compound, preparation method and applications thereof
10/09/2013CN102295635B Antitumor medicament tetralin amide compounds and pharmaceutically acceptable salts thereof as well as preparation method and application of antitumor medicament tetralin amide compounds
10/09/2013CN102219725B Benzohetercyclic compound as well as preparation method and applications thereof
10/09/2013CN102050794B Quinoxalin derivative and organic LED (Light-Emitting Diode) containing same
10/09/2013CN101821254B Adrenergic compounds
10/09/2013CN101801954B Compounds and compositions as modulators of GPR119 activity
10/09/2013CN101659638B Organic compound and organic electroluminescent device containing same
10/08/2013US8552206 NF-κB inhibitors and uses thereof
10/08/2013US8552205 Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides
10/08/2013US8552198 Benzimidazole compound crystal
10/08/2013US8552190 Tristhiourea tripodal metal complexes
10/08/2013US8552031 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
10/08/2013US8552015 Quinazolinone derivatives and their use as CB agonists
10/08/2013US8551999 Heterocyclic compound and pharmaceutical composition thereof
10/08/2013US8551990 Anxiolytic compounds
10/08/2013US8551989 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
10/08/2013US8551988 Benzimidazole derivatives: preparation and pharmaceutical applications
10/08/2013US8551987 Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate
10/08/2013US8551985 Carbinol derivatives having heterocyclic linker
10/08/2013US8551982 Benzodioxane inhibitors of leukotriene production
10/08/2013US8551978 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
10/08/2013CA2742709C Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/08/2013CA2721222C Fungicidal active compound combinations
10/08/2013CA2687321C Pyridyl piperidine orexin receptor antagonists
10/08/2013CA2682859C Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl)indazole for treatment of abnormal cell growth in mammals
10/08/2013CA2674358C Crystalline forms of solvated ilaprazole
10/08/2013CA2558389C Process for the synthesis of a cxcr4 antagonist
10/08/2013CA2531508C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/08/2013CA2359244C .omega.-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
10/03/2013WO2013149185A1 Processes for preparing tubulysin derivatives and conjugates thereof
10/03/2013WO2013148857A1 Triazole derivatives as hsp90 inhibitors
10/03/2013WO2013148603A1 Cinnoline derivatives as as btk inhibitors
10/03/2013WO2013148537A1 Substituted spirobicyclic compounds and methods of use
10/03/2013WO2013148174A1 New anti-mycobacterial drugs against tuberculosis
10/03/2013WO2013147458A1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 1080